ProKidney share price logo

ProKidney

NASDAQ: PROK

Small Cap

$1.72

+0.01

(+0.58%)

as on

ProKidney Stock Performance

as on October 3, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $1.66
    $1.73
    downward going graph

    3.49%

    Downside

    0.58%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.30
    $3.48
    downward going graph

    24.42%

    Downside

    102.32%

    Upside

    downward going graph

ProKidney share price movements today

Previous Close
$1.71
Open
$1.72
Volume
1.4M
Market Cap
$682.6M
Day's Low - High
$1.66 - $1.73
52 Week Low - High
$1.30 - $3.48

ProKidney Historical Returns

1 Month Return
-10.42 %
3 Month Return
-15.27 %
1 Year Return
-37.23 %
3 Year Return
-61.61 %
5 Year Return
0 %

ProKidney Stock Fundamentals & Key Indicators

Check ProKidney market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$682.6M

EPS (TTM)

-0.57

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.97

Industry PE ratio

-6.16

PEG Ratio

3.37

EBITDA

-160.8M

Revenue (TTM)

818.0K

Profit Margin

-252.57%

Return On Equity TTM

8.83%

ProKidney vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ProKidney with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$682.6MNA-2.97-252.57%0.00%
StrongBuy$44.1B609.62%-23.340.00%0.00%
Neutral$75.4B-44.29%-24.08-12.57%0.00%
StrongBuy$132.5B180.98%30.1986.04%0.00%
Buy$78.1B28.80%17.6784.86%0.50%

Stock Returns calculator for ProKidney Stock including INR - Dollar returns

The ProKidney stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

ProKidney investment value today

Current value as on today

₹68,125

Returns

-₹31,875

(-31.87%)

Returns from ProKidney Stock

-₹37,226 (-37.23%)

Dollar Impact

₹5,352 (+5.35%)

Analyst Recommendation on ProKidney Stock

Based on 2 analysts

BUY

50.00%

Buy

50.00%

Hold

0.00%

Sell

Based on 2 analysts, 50% of analysts recommend a 'BUY' rating for ProKidney. Average target price of $6.25

ProKidney Share Price Target

Get share price movements and forecasts by analysts on ProKidney.

What analysts predicted

72.48%UPSIDE

Target Price

$6.25

Current Price

$1.72

Analyzed by

2 Analysts

High

$12

Target

$6.25

Low

$12

ProKidney target price $6.25, a slight upside of 72.48% compared to current price of $1.72. According to 2 analysts rating.

Indian Investors' Interest in ProKidney Stock

Search interest for ProKidney Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-53% versus previous 30 day period

ProKidney Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
0
0
0
0
0
0
Gross Profit
-
-
-
-
0
0
0
-1
-1
0
Operating Income
-24
-40
-43
-48
-41
-39
-38
-45
-44
-48
EBITDA
-17
-34
-37
-41
-35
-34
-33
-40
-41
-44
Interest Expense
0
0
0
0
-
0
0
0
0
0
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-18
-35
-38
-43
-37
-36
-35
-42
-42
-46
Income Tax Expense
2
0
0
-2
0
0
0
-1
-20
-
Net Income
-5
-9
-12
-17
-16
-16
-16
-19
-22
-28
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
100.00%
100.00%
100.00%
-544.00%
-534.96%
100.00%

ProKidney Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Total Revenue
-
-
-
-
-
0
0
Gross Profit
-
-
-
-
-
0
0
Operating Income
-79
-27
-55
-153
-151
-183
-165
EBITDA
-18
-26
-53
-143
-125
-158
-144
Interest Expense
-
-
-
0
0
0
0
Depreciation
0
0
1
3
3
5
6
Income Before Tax
-79
-26
-55
-147
-129
-163
-151
Income Tax Expense
0
0
0
0
5
0
0
Net Income
-79
-26
-55
-108
-35
-61
-68
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
100.00%

ProKidney Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-21
-35
-38
-41
-37
-36
-16
-40
-42
-46
Operating Cash Flow
-25
-34
-38
-29
-29
-31
-26
-32
-41
-40
Investing Cash Flow
-95
58
28
-81
28
18
29
28
34
12
Financing Cash Flow
-9
0
139
4
0
0
7
17
0
0
Change in Cash
-130
23
130
-106
-1
-12
10
13
-6
-27

ProKidney Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Net Income
0
-26
-55
-148
-135
-163
-151
Operating Cash Flow
0
-25
-50
-77
-90
-126
-120
Investing Cash Flow
0
-5
-5
-1
-329
20
103
Financing Cash Flow
0
19
71
548
-9
144
25
Change in Cash
0
-10
15
469
-429
38
9

Global Institutional Holdings in ProKidney

Check out the Institutions with significant holdings in ProKidney.

Funds
Holdings
iShares
1.93%
Vanguard
0.86%
VANGUARD INDEX FUNDS
0.55%
Morgan Stanley Insight Fund
0.54%
Fidelity Concord Street Trust
0.51%

ProKidney News & Key Events

  • img

    Today's Timeline - 27 August

    Wed, 05:00 PM

    -

    ProKidney announces participation in Citi and Morgan Stanley healthcare conferences in September 2025.

Insights on ProKidney

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PROK stock has moved up by 7.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 604.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 82.2% return, outperforming this stock by 146.1%

About ProKidney

ProKidney Corp. is a biotechnology firm currently in the clinical trial phase, specializing in the development of innovative cell-based treatments. Their flagship product is Renal Autologous Cell Therapy (RAC-T), a unique cellular admixture derived from a patient's own cells. RAC-T is undergoing significant clinical evaluation; it is concurrently in Phase III and Phase II trials for individuals with moderate to severe diabetic kidney disease. Furthermore, the company is conducting a Phase I clinical trial to assess RAC-T's potential for patients born with congenital anomalies affecting the kidneys and urinary tract. The company was established in 2015 and operates from its headquarters in Winston-Salem, North Carolina.
OrganisationProKidney
Headquarters2000 Frontis Plaza Blvd., Winston-Salem, NC, 27103, US
IndustryBiotechnology
CEOBruce Culleton

Key Management of ProKidney

Name

Title

Mr. Todd C. Girolamo Esq., J.D., M.B.A.

Chief Legal Officer & Secretary

Mr. Kenneth Locke

Chief Technical Officer

Dr. Joseph M. Stavas M.D., M.P.H.

Senior Vice President of Interventional Procedures

Dr. Emily Butler Ph.D.

Senior VP of Biometric

Dr. Bruce Culleton M.D.

CEO & Director

Mr. James Coulston CPA

Chief Financial Officer

Mr. Richard Williams

Chief Information Officer

Ms. Carla Poulson

Chief People Officer

Dr. Darin J. Weber Ph.D.

Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access

Mr. Gregory P. Madison

Chief Commercial Officer

FAQs

What is ProKidney share price today?

ProKidney share price today is $1.72 as on at the close of the market. ProKidney share today touched a day high of $1.73 and a low of $1.66.

What is the 52 week high and 52 week low for ProKidney share?

ProKidney share touched a 52 week high of $3.48 on and a 52 week low of $1.30 on . ProKidney stock price today i.e. is closed at $1.72,which is 50.57% down from its 52 week high and 32.31% up from its 52 week low.

What is ProKidney's market capitalisation today?

ProKidney market capitalisation is $0.00T as on .

How to invest in ProKidney Stock (PROK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ProKidney on INDmoney app. Click on Buy button.

What is the minimum amount required to buy ProKidney Stock (PROK) from India?

Indian investors can start investing in ProKidney (PROK) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in ProKidney stock (as per the Rupee-Dollar exchange rate as on ). Based on ProKidney share’s latest price of $1.72 as on October 3, 2026 at 8:46 am IST, you will get 5.8140 shares of ProKidney. Learn more about fractional shares .